A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
published in: Annals of the Rheumatic Diseases
date of publication: 2004-04-13
language: English
main subject: placebo, multicenter clinical trial, rheumatoid arthritis, methotrexate, anakinra
Cites articles 24
Date
Title
Article - wd:Q35554448